Standardizing the Response to Category II Tracings during Induction with Oxytocin: A Cost-Effectiveness Analysis

Abstract

Background Oxytocin is one of the most frequently used medications in obstetrics. It is generally considered to be safe and effective for induction and augmentation of labor but has been implicated in uterine hyperstimulation and adverse fetal outcomes. The management of labor with oxytocin in response to changes in fetal status remains an area of debate.

Objective This study sought to assess the cost-effectiveness of reducing or ceasing oxytocin administration in response to Category II fetal heart rate tracings.

Study Design A decision-analytic model was built using TreeAge 2016 software (TreeAge Software Inc.) with probabilities, costs, and utilities derived from the literature. Primary outcomes included cerebral palsy (CP), neonatal mortality, and mode of delivery. Secondary outcomes included cost per quality-adjusted life year (QALY; cost-effectiveness threshold set at $100,000/QALY), admission to the neonatal intensive care unit (NICU), and low 5-minute Apgar score (<7). Sensitivity analyses were performed to determine the robustness of our baseline assumptions.

Results In a theoretical cohort of 900,000 women (estimated number of women undergoing induction at term in the United States), decreasing or stopping oxytocin in response to Category II tracings prevented 12,510 NICU admissions, 4,410 low Apgar scores, 204 neonatal deaths, and 126 cases of CP. However, there were 81,900 more cesarean deliveries. The strategy cost $356 million more, but was cost-effective with an ICER of $9,881.5 per QALY. Sensitivity analysis revealed that the intervention would be cost-effective up to a cesarean rate of 54%.

Conclusion Decreasing or stopping oxytocin in response to Category II fetal heart rate tracings is cost-effective. This intervention increases the rate of cesarean deliveries but reduces neonatal morbidity and mortality. Further work on this guideline should be performed to ascertain how the approach using different aspects of the Category II tracing to guide care might lead to similar improved outcomes without increasing the cesarean delivery rate.

Keywords

Category II tracing - cost-effectiveness - fetal heart rate monitoring - induction - labor management - oxytocin

Condensation

Decreasing oxytocin in response to Category II tracings is cost-effective over a wide range of assumptions.

Note

This study was presented as a poster presentation at the Society for Maternal Fetal Medicine Pregnancy Meeting 2017, Las Vegas, Nevada (Abstract #430).

• References

• 1 American College of Obstetricians and Gynecologists. Practice bulletin no. 116: Management of intrapartum fetal heart rate tracings. Obstet Gynecol 2010; 116 (05) 1232-1240
• 2 Cahill A, Tuuli MG, Stout MJ, Deych E, Shannon W, Macones GA. 345: Electronic fetal monitoring (EFM) patterns are associated with acidemia. Am J Obstet Gynecol 2016; 214 (01) S194-S195
• 3 Clark SL, Meyers JA, Frye DK, Garthwaite T, Lee AJ, Perlin JB. Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor. Am J Obstet Gynecol 2015; 212 (04) 494.e1-494.e6
• 4 Simpson KR, James DC. Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns. Am J Obstet Gynecol 2008; 199 (01) 34.e1-34.e5
• 5 Heuser CC, Knight S, Esplin MS. , et al. Tachysystole in term labor: incidence, risk factors, outcomes, and effect on fetal heart tracings. Am J Obstet Gynecol 2013; 209 (01) 32.e1-32.e6
• 6 Clark S, Belfort M, Saade G. , et al. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes. Am J Obstet Gynecol 2007; 197 (05) 480.e1-480.e5
• 7 Moster D, Lie RT, Irgens LM, Bjerkedal T, Markestad T. The association of Apgar score with subsequent death and cerebral palsy: a population-based study in term infants. J Pediatr 2001; 138 (06) 798-803
• 8 Thorngren-Jerneck K, Herbst A. Low 5-minute Apgar score: a population-based register study of 1 million term births. Obstet Gynecol 2001; 98 (01) 65-70
• 9 United States Department of Labor Bureau of Labor Statistics. Consumer Price Indices. Washington, DC: United States Bureau of Labor Statistics; 2016
• 10 Chung A, Macario A, El-Sayed YY, Riley ET, Duncan B, Druzin ML. Cost-effectiveness of a trial of labor after previous cesarean. Obstet Gynecol 2001; 97 (06) 932-941
• 11 Bor P, Ledertoug S, Boie S, Knoblauch NO, Stornes I. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial. BJOG 2016; 123 (01) 129-135
• 12 Lemieux J, Mulligan T. Trends in inpatient hospital prices, 2008 to 2010. Am J Manag Care 2013; 19 (03) e106-e113
• 13 Olsen MA, Butler AM, Willers DM, Gross GA, Hamilton BH, Fraser VJ. Attributable costs of surgical site infection and endometritis after low transverse cesarean delivery. Infect Control Hosp Epidemiol 2010; 31 (03) 276-282
• 14 Tita AT, Szychowski JM, Boggess K. , et al; C/SOAP Trial Consortium. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016; 375 (13) 1231-1241
• 15 Phibbs CS, Schmitt SK. Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. Early Hum Dev 2006; 82 (02) 85-95
• 16 March of Dimes Perinatal Data Center. Special Care Nursery Admissions. National Perinatal Information Center. 2011. Available at: https://www.marchofdimes.org/peristats/pdfdocs/nicu_summary_final.pdf ; Accessed February 3, 2017
• 17 Grobman WA, Dooley SL, Welshman EE, Pergament E, Calhoun EA. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?. Prenat Diagn 2002; 22 (13) 1195-1200
• 18 Carroll AE, Downs SM. Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics 2006; 117 (5, Pt 2): S287-S295
• 19 Carroll AE, Downs SM. Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 2009; 155 (01) 21-25 , 25.e1–25.e5
• 20 Angeja AC, Washington AE, Vargas JE, Gomez R, Rojas I, Caughey AB. Chilean women's preferences regarding mode of delivery: which do they prefer and why?. BJOG 2006; 113 (11) 1253-1258
• 21 Blair E, Watson L, Badawi N, Stanley FJ. Life expectancy among people with cerebral palsy in Western Australia. Dev Med Child Neurol 2001; 43 (08) 508-515
• 22 NCFHS CDC, editor. NCHS. Health, United States, 2011: With special feature on socioeconomic status and health. Hyattsville, MD: U.S. Government Printing Office; 2012
• 23 Schnettler WT, Rogers J, Barber RE, Hacker MR. A modified fetal heart rate tracing interpretation system for prediction of cesarean section. J Matern Fetal Neonatal Med 2012; 25 (07) 1055-1058